Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status

A. Szymanowska, M. Skrzypski, R. Rosell, M. Taron, M. Perez-Cano, W. Rzyman, R. Rzepko, M. Jarzab, T. Muley, H. Dienemann, E. Jassem, J. Jassem (Gdansk, Gliwice, Poland; Badalona, Barcelona, Spain; Heidelberg, Germany)

Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Session: Discovery of novel targets in lung disease by means of functional genomics
Session type: Oral Presentation
Number: 2787
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Szymanowska, M. Skrzypski, R. Rosell, M. Taron, M. Perez-Cano, W. Rzyman, R. Rzepko, M. Jarzab, T. Muley, H. Dienemann, E. Jassem, J. Jassem (Gdansk, Gliwice, Poland; Badalona, Barcelona, Spain; Heidelberg, Germany). Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status. Eur Respir J 2008; 32: Suppl. 52, 2787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009


Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


Different expression of miRNA in non-small cell lung cancer according to its clinical stage
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008


24h-blood profile gene expression biomarkers of the response to bevacizumab-erlotinib (BE) in advanced non-squamous non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016

Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Gene modules in non-small cell lung cancer
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009



Gene expression profiles predict survival of patients with advanced non-small cell lung cancers
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010

Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005



Gene expression analysis in patients with non-small cell lung cancer subjected to thoracotomy
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009


Analysis of the prognosis value of the mitochondrial activity in resected non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010


MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

Expression of ERCC1 in normal and tumor tissues in non-small cell lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


A non-small cell lung cancer modelling by endogenous κ-ras manipulation
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

Treatment of  non-small cell lung cancer (NSCLC) - the state of the art and beyond
Source: International Congress 2017 – State of the art session: "Lung cancer"
Year: 2017


XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012

Is MIF -173G/C polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility?
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010